Technology transfer—from agnogenic portal vein thrombosis to agnogenic myeloid metaplasia
✍ Scribed by Charles L. Witte; Marlys H. Witte
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 415 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med Scullard GH, Smith CI, Merigan TC, et al. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81:987-991. Hoofnagle JG, Dusheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96447-449. Brechot C, Hadchouel M, Scotto J, et al. State of hepatitis B viral DNA in hepatocytes of patients with hepatitis B surface antigenpositive and negative liver disease. Proc Natl Acad Sci USA 1981; Wands J, Fujita YK, Isselbacher K, et al. Identification and transmission of hepatitis B related variants. Proc Natl Acad Sci USA London WT, Drew JS, Blumberg BS, et al. Association of graft survival with host response to hepatitis B infection in patients with kidnev transdants.